Designation of a Class of Employees for Addition to the Special Exposure Cohort, 68460 [2011-28575]

Download as PDF 68460 Federal Register / Vol. 76, No. 214 / Friday, November 4, 2011 / Notices addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On October 18, 2011, the Secretary of HHS designated the following class of employees as an addition to the SEC: All Atomic Weapons Employees who worked at Vitro Manufacturing in Canonsburg, Pennsylvania, from January 1, 1960 through September 30, 1965, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort. This designation will become effective on November 17, 2011, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, NIOSH, 4676 Columbia Parkway, MS C– 46, Cincinnati, OH 45226, Telephone (877) 222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2011–28574 Filed 11–3–11; 8:45 am] in any area of the Ames Laboratory at Iowa State University during the period from August 13, 1942 through December 31, 1970, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more classes of employees included in the Special Exposure Cohort. This designation will become effective on November 17, 2011, unless Congress provides otherwise prior to the effective date. After this effective date, HHS will publish a notice in the Federal Register reporting the addition of this class to the SEC or the result of any provision by Congress regarding the decision by HHS to add the class to the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, NIOSH, 4676 Columbia Parkway, MS C– 46, Cincinnati, OH 45226, Telephone (877) 222–7570. Information requests can also be submitted by Email to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2011–28575 Filed 11–3–11; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct BILLING CODE 4163–19–P Office of the Secretary, HHS. ACTION: Notice. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice of a decision to designate a class of employees from the Ames Laboratory at Iowa State University as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On October 18, 2011, the Secretary of HHS designated the following class of employees as an addition to the SEC: mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: All Department of Energy (DOE) employees, its predecessor agencies, and its contractors and subcontractors who worked VerDate Mar<15>2010 17:06 Nov 03, 2011 Jkt 226001 Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Jayant Jagannathan, M.D., University of Virginia Medical Center: Based on the report of an investigation conducted by the University of Virginia (UVA) and additional analysis conducted by ORI in its oversight review, ORI found that Dr. Jayant Jagannathan, former Resident Physician at UVA Medical Center, engaged in research misconduct by plagiarizing research supported by National Institutes of Health (NIH) research and training awards and by NIH intramural research funds from the National Institute of Neurological Disorders and Stroke (NINDS), Surgical Neurosurgery Branch (NSB), and from the National Institute of Dental and Craniofacial Research (NIDCR). ORI found that the Respondent engaged in research misconduct by including, in five publications, large SUMMARY: PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 amounts of text and an illustration that he plagiarized from publications supported by the following NIH grant awards: T32 CA09677, P01 HL024136, R01 HL059157, P50 CA090270, M01 RR01346, R01 CA075979, R01 DK064169, R01 NS027544, R01 NS052406, and K08 NS002197,1 and by intramural funds from the Surgical Neurosurgery Branch, NINDS, and from NIDCR. Publications in which Respondent reported plagiarized material were: 1. Jagannathan, J., Li, J., Szerlip, N., Vortmeyer, A.O., Lonser, R.R., Oldfied, E.H., Zhuang, Z. ‘‘Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.’’ Neurosurgery 64:4–14, 2009 (to be retracted); 2. Jagannathan, J., Prevedello, D.M., Dumont, A.S., Laws, E.R. ‘‘Cellular Signaling Molecules as Therapeutic Targets in the Treatment of Glioblastoma Multiforme.’’ Neurosurgical Focus 20(4):E8, 2006 (retracted ‘‘due to plagiarism,’’ Neurosurgical Focus 30(2):E8r, 2011); 3. Kanter, A.S., Jagannathan, J., Shaffrey, C.I., Ouellet, J.A., Mummaneni, P.V. ‘‘Inflammatory and dysplastic lesions involving the spine.’’ Neurosurgical Clinics of North America 19(1):93–109, 2008; 4. Jagannathan, J., Dumont, A.S., Prevedello, D.M., Oskouian, R.J., Lopes, B., Jane, J.A. Jr, Laws, E.R. Jr. ‘‘Genetics of pituitary adenomas: Current theories and future implications.’’ Neurosurgical Focus 19(5):E4, 2005 (retracted ‘‘due to plagiarism,’’ Neurosurgical Focus 30(2):E4r, 2011); 5. Jagannathan, J. ‘‘Role of calcium influx and modulation of local neurotransmitters as hallmarks of pediatric traumatic brain injury.’’ Biomarkers Med. 3:95–97, 2009 (retracted online 9/11/2010). Dr. Jagannathan has entered into a Voluntary Settlement Agreement (Agreement) and has voluntarily agreed for a period of four (4) years, beginning on October 20, 2011: (1) To have his research supervised; Respondent agreed to ensure that prior to the submission of an application for U.S. Public Health Service (PHS) support for a research project on which his participation is proposed and prior 1 T32 CA09677, Radiation Biology Training Grant,’’ A. Kennedy, P.I. P01 HL024136, ‘‘Mechanisms of Remodeling in Chronic Airway Inflammation,’’ G. Caughey, P.I. HL059157, ‘‘Angioproteins in Airway Vascular Leak and Angiogenesis,’’ D. McDonald, P.I. P50 CA090270, ‘‘UTMDACC Cancer Center SPORE in prostate cancer,’’ C. Logothetis, P.I. M01 RR01346, ‘‘UTHSC GCRC,’’ R. Clark, P.I. R01 CA075979, ‘‘Mechanisms for Pituitary Tumorigenesis,’’ S. Melmed, P.I. R01 DK064169, ‘‘Metabolic Consequences of Sccurin Disruption,’’ S. Melmed, P.I. R01 NS027544, ‘‘Loss of Developmental Plasticity after Head Injury,’’ D.A. Hovda, P.I. R01 NS052406, ‘‘Age-dependent Ketone Metabolism after Brain Injury,’’ M.L. Prims, P.I. K08 NS002197, ‘‘NMDA Receptor Dysfunction after Traumatic Brain Injury,’’ C.C. Christopher, P.I. E:\FR\FM\04NON1.SGM 04NON1

Agencies

[Federal Register Volume 76, Number 214 (Friday, November 4, 2011)]
[Notices]
[Page 68460]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28575]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Designation of a Class of Employees for Addition to the Special 
Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HHS gives notice of a decision to designate a class of 
employees from the Ames Laboratory at Iowa State University as an 
addition to the Special Exposure Cohort (SEC) under the Energy 
Employees Occupational Illness Compensation Program Act of 2000. On 
October 18, 2011, the Secretary of HHS designated the following class 
of employees as an addition to the SEC:

    All Department of Energy (DOE) employees, its predecessor 
agencies, and its contractors and subcontractors who worked in any 
area of the Ames Laboratory at Iowa State University during the 
period from August 13, 1942 through December 31, 1970, for a number 
of work days aggregating at least 250 work days, occurring either 
solely under this employment or in combination with work days within 
the parameters established for one or more classes of employees 
included in the Special Exposure Cohort.

    This designation will become effective on November 17, 2011, unless 
Congress provides otherwise prior to the effective date. After this 
effective date, HHS will publish a notice in the Federal Register 
reporting the addition of this class to the SEC or the result of any 
provision by Congress regarding the decision by HHS to add the class to 
the SEC.

FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, 
Division of Compensation Analysis and Support, NIOSH, 4676 Columbia 
Parkway, MS C-46, Cincinnati, OH 45226, Telephone (877) 222-7570. 
Information requests can also be submitted by Email to DCAS@CDC.GOV.

John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 2011-28575 Filed 11-3-11; 8:45 am]
BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.